Botulinum toxin in patients with multiple sclerosis
Botulinum toxin in patients with multiple sclerosis
About this item
Full title
Author / Creator
Publisher
Germany
Journal title
Language
English
Formats
Publication information
Publisher
Germany
Subjects
More information
Scope and Contents
Contents
Nearly all patients with multiple sclerosis (MS) will develop spasticity in the course of their disease. This symptom accounts for most of the handicap and impairment in the quality of life. Treatment with botulinum toxin will enable an efficient and safe alleviation of spasticity and the problems involved, given a realistic definition of the thera...
Alternative Titles
Full title
Botulinum toxin in patients with multiple sclerosis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_754557501
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754557501
Other Identifiers
ISSN
0340-5354
E-ISSN
1432-1459
DOI
10.1007/s00415-006-1106-y